Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Frontline policing has never been more important in South Yorkshire as officers save lives with just a few clicks ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

A new study shows that oxytocin nasal spray helps mothers with postpartum depression interact more positively with their babies.

People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

Researchers at Radboud University and the Radboudumc found that mothers with postpartum depression benefit from oxytocin ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the ...

ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.

Nasal inhalers like Vicks and Yadom are popular remedies for congestion, but its overuse can cause more harm than good ...

Evoke Pharma's stock soared 168% on Wednesday after the company announced it had received a new U.S. patent that could extend ...